$MSTX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board

Jun 25, 2014 at 10:14 AM

$MSTX Up to date company activities and other important information about $MSTX

$MSTX

DD Notes ~ http://www.ddnotesmaker.com/MSTX

##### recent news/filings ~ source: finance.yahoo.com

Tue, 24 Jun 2014 14:19:22 GMT ~ Mast Therapeutics' MST-188 Would Fit Well In Merck's Drug Development Pipeline
read full: http://seekingalpha.com/article/2283763-mast-...urce=yahoo
*********************************************************

Fri, 20 Jun 2014 20:31:40 GMT ~ MAST THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vot
read full: http://biz.yahoo.com/e/140620/mstx8-k.html
*********************************************************

Thu, 19 Jun 2014 20:15:00 GMT ~ Mast Announces Appointment Of Howard C. Dittrich M.D. To Board of Directors
- SAN DIEGO, June 19, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that Howard C. Dittrich, M.D., F.A.C.C., has joined its Board of Directors. Dr. Dittrich, a cardiologist by training, has more than 20 years of experience in cardiac therapeutic research and clinical development. "We are delighted to welcome Howard to the Board," stated Jack Lief, Chair of Mast's Board of Directors. "His medical training and extensive clinical development and regulatory affairs experience, particularly with cardiovascular agents, is highly relevant to Mast's development programs and will enrich our expertise. We look forward to benefitting from his contributions and insights." Dr. Dittrich currently serves as Chief Medical Officer of Sorbent Therapeutics, a privately-held biopharmaceutical company developing therapies for cardiovascular and renal diseases, a position he has held since February 2012. Previously, from June 2003 until it was acquired by Merck & Co., Inc. in September 2007, Dr. Dittrich served as Chief Medical Officer and Senior Vice President of Clinical and Regulatory Affairs of NovaCardia, Inc., a clinical-stage pharmaceutical company focused on cardiovascular diseases, and, from September 2007 to June 2011, he co-founded and served as Chief Medical Officer of Sequel Pharmaceuticals, Inc., a privately-held pharmaceutical company spun out from NovaCardia following its acquisition by Merck. Prior to NovaCardia, from 1996 to 2002, Dr. Dittrich held executive positions overseeing clinical development and regulatory affairs at Molecular Biosystems, Inc. and Alliance Pharmaceutical Corp., during which time he was instrumental in gaining U.S. Food and Drug Administration approval of two cardiovascular imaging agents. From 1984 to 1996, he was a full-time faculty member of the Department of Medicine at the University of California, San Diego (UCSD) and, from 1996 to 2011, he served part-time as Clinical Professor of Medicine at UCSD. Dr. Dittrich holds a B.S. d...
read full: http://finance.yahoo.com/news/mast-announces-...00262.html
*********************************************************

Mon, 16 Jun 2014 12:04:21 GMT ~ Mast Therapeutics initiates sub-study within Phase 3 EPIC trial
read full: http://www.theflyonthewall.com/permalinks/ent...EPIC-trial
*********************************************************

Mon, 16 Jun 2014 12:00:00 GMT ~ Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC Trial
- SAN DIEGO, June 16, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in line with prior guidance, it has initiated patient enrollment in a sub-study within EPIC, its pivotal phase 3 study of MST-188 in sickle cell disease, to investigate and quantify the effect of MST-188 on tissue oxygenation, which will be measured utilizing a non-invasive, FDA-approved device. MST-188 has been shown to reduce viscosity and adhesive frictional forces in blood and improve microvascular blood flow. Improvements in the flow of oxygen-carrying blood to tissues and organs can be expected to improve tissue oxygenation, shorten the duration of vaso-occlusive crisis, and limit tissue damage and end-organ dysfunction and failure. Brian M. Culley, Chief Executive Officer, said: "Organ failure, which is the leading cause of premature death in adults with sickle cell disease, is thought to be the consequence of a lifetime of repeated vaso-occlusive events and the resulting ischemia. We believe that measuring effects on microvascular blood flow and tissue oxygenation during vaso-occlusive crisis will be useful to understanding MST-188's potential to improve long-term outcomes for sickle cell patients where multi-decade, survival trials are impractical. MST-188 has already demonstrated an ability to improve microvascular blood flow. Now, this sub-study will demonstrate whether MST-188 also improves tissue oxygenation. Together, these data will provide insight into the potential for MST-188 to reduce end-organ failure and associated premature death in individuals with sickle cell disease."
read full: http://finance.yahoo.com/news/mast-therapeuti...00240.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=MSTX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=MSTX&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/MSTX/company-info
Ticker: $MSTX
OTC Market Place: Not Available
CIK code: 0001160308
Company name: Mast Therapeutics, Inc.
Company website: http://www.masttherapeutics.com
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/MSTX/filings
Latest financials: http://www.otcmarkets.com/stock/MSTX/financials
Latest news: http://www.otcmarkets.com/stock/MSTX/news - http://finance.yahoo.com/q/h?s=MSTX+Headlines

Major holdings: http://data.cnbc.com/quotes/MSTX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=MSTX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/MSTX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=MSTX

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Mast+Therapeutics%...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.masttherapeutics.com
Alexa: http://www.alexa.com/siteinfo/http://www.mast...utics.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.masttherapeutics.com

Short Sales: http://www.otcmarkets.com/stock/MSTX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/MSTX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/MSTX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=MSTX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=MSTX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=MSTX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=MSTX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=MSTX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=MSTX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=MSTX
Balance Sheet: http://finance.yahoo.com/q/bs?s=MSTX
Cash Flow: http://finance.yahoo.com/q/cf?s=MSTX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/MSTX
Bloomberg: http://www.bloomberg.com/quote/MSTX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=MSTX
Bussinessweek: http://investing.businessweek.com/research/st...icker=MSTX
Barchart: http://www.barchart.com/quotes/stocks/MSTX
OTC Short Report: http://otcshortreport.com/index.php?index=MSTX
Investopedia: http://www.investopedia.com/markets/stocks/MSTX/?wa=0

http://www.pennystocktweets.com/stocks/profile/MSTX

##### last known share structure ~ source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com

DD Notes ~ http://www.ddnotesmaker.com/MSTX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Battery Testing Market to Reach $45 Billion by 2033

There's a gold rush happening in the battery testing market, as ambitious as any I've seen in my trading years. The market's taking off faster than a Wall Street trader on a bull market open, projected to skyrocket from $13.03 billion in 2026 to $45.06 billion by 2033. That's a hefty 19.4% compound annual growth rate, a pace that'll have big money and new players...

Aura Shakes Up Q3 with AI Innovations and Revenue Boost

You ever want to see a company not just keep pace but actually lead the dance? That's Aura for you—and they're quite the partner this quarter. Revenue's jumped up by a neat 24% in Q3 2026, ringing in at $87.9 million. If there's one thing investors can't turn a blind eye to, it's numbers like that. All that amid Aura's new strides into the AI frontier, spearheaded by...

Housing Markets Realign: Shifting Generational Burdens

Riding the Generational Equity Wave Here's a kicker for you—the housing game has warped in ways that have flummoxed even the sharpest minds nodding along at economic seminars. Elder millennials back in the early 30s bracket once rode high with those mythical low mortgage rates—magic numbers scratching the underbelly of 3%, if you can believe it. But in today's...

Webull Faces Class Action Over China Ties Missteps

What's Brewing with Webull? Troubling allegations have bubbled to the surface regarding Webull Corporation, now in the crosshairs of a securities class action. The heart of this legal storm is the claim that Webull, under the ticker NASDAQ:BULL, allegedly disguised its deep-seated ties with China. And boy, when those revelations hit the news on October 7, 2026, it sent...

Tuya Debuts Skill for Meta Muse: Smart Home Mastery

Connecting the Dots in Smart Homes You ever find yourself fiddling around with three remotes to dim the lights and crank up the thermostat? I reckon you're not alone. Well, Tuya Smart just threw a curveball into the mix. They've teamed up with Meta's Muse to create Tuya Cloud Devices, an open-source Skill that's designed to let folks control their smart home tech with...

How to Assess a True Christian School Experience

Making the Right Spiritual Choice for Your Kids Deciding on a Christian school isn't just about academics or facilities—it’s a spiritual journey that shapes your child's worldview and relationship with God. In Kearney, Nebraska, where strong Christian values are prevalent, Anthony Splittgerber of Zion Lutheran School breaks down for HelloNation how faith-based...

LiuGong Pushes Sustainability at 2026 Dealer Conference

The Road to Green: LiuGong’s Ambitious Vision In a world where more heads are turning towards sustainability, LiuGong stepped up and showcased its green aspirations with flare at the 2026 Global Dealer Conference held from November 10 to 12 in Liuzhou, China. Over 2,000 attendees, ranging from dealers to customers, were in attendance to witness what seemed to be both a...

Water Wings Swim School Splashes into Billings

By Riley Hayes Updated Nov 11, 2026 Category News Views 122

Billings Dives into the Swim School Scene Well, folks, Billings is about to get its feet wet with something new and well-needed in the local scene. Come November 21, Montana will welcome its first dedicated swim school as Water Wings opens shop right here in Billings at 2618 King Ave W. This ain't just run-of-the-mill comic relief on disaster-preparedness. We're talking...

GAMG Strengthens Shareholder Services with Transition

Tech Upgrade for GAMG's Operations Hard to believe it's taken this long, but Global Asset Management Group (OTCQB: GAMG) has finally updated their playbook, folks. With its recent switch to Transfer Online as their new transfer agent, we've got ourselves a company stepping up its infrastructure game. This isn't just a run-of-the-mill shift—this move represents a...

Azazie Pops Up in Citrus Fields with Bridal Bliss

Azazie Steps into the Sunshine State Alright, here we go—Azazie's taking their whole bridal catalogue circus down to the heart of Florida's citrus country this November. Polk City, mark your calendars for November 14. Now, I'm not the type who usually gets jazzed about gowns and lace, but this pop-up event at Ever After Farms Citrus just might turn a few heads, even...